A clinical trial titled "Evaluation of 25(OH)D3 and LL-37 Levels in Periimplant Sulcus Fluid" is listed as recruiting as of November 3, 2026. The study, registered as NCT07280754, is examining levels of 25(OH)D3 and LL-37 found in periimplant sulcus fluid. No phase is specified for this trial in the available registration data.
The trial status reflects that enrollment is currently open according to the registry entry. No outcome data or results have been posted for this study at this time. LL-37 remains classified as an unapproved compound used only in research settings.
As with all trial updates, this listing reflects only the recruitment status and stated objective of the study. No conclusions about safety or effectiveness can be drawn from the fact that a trial is recruiting. Further details on study design, eligibility, and methodology are available through the official registry listing.
Readers interested in background on this compound can consult the LL-37 overview page for additional context.